Cited by 885Genetic Neurodegenerative DiseasesMetabolism and Genetic DisordersMitochondrial Function and Pathology

The DOI matches its Crossref record; 40 of the 41 references it cites were found in a registry or an index.

Oxidative damage and metabolic dysfunction in Huntington's disease: Selective vulnerability of the basal ganglia

Browne, Susan E., Bowling, Allen C., Macgarvey, Usha, Baik, M. Jay, Berger, Stephanie C., Muquit, Miratul M. K., Bird, Edward D., Beal, M. Flint·1997·Annals of Neurology

DOI 10.1002/ana.410410514

Open this paper in CoChat — free account

Abstract

The etiology of the selective neuronal death that occurs in Huntington's disease (HD) is unknown. Several lines of evidence implicate the involvement of energetic defects and oxidative damage in the disease process, including a recent study that demonstrated an interaction between huntingtin protein and the glycolytic enzyme glyceraldehyde‐3‐phosphate dehydrogenase (GAPDH). Using spectrophotometric assays in postmortem brain tissue, we found evidence of impaired oxidative phosphorylation enzyme activities restricted to the basal ganglia in HD brain, while enzyme activities were unaltered in three regions relatively spared by HD pathology (frontal cortex, parietal cortex, and cerebellum). Citrate synthase‐corrected complex II‐III activity was markedly reduced in both HD caudate (−29%) and putamen (−67%), and complex IV activity was reduced in HD putamen (−62%). Complex I and GAPDH activities were unaltered in all regions examined. We also measured levels of the oxidative damage product 8‐hydroxydeoxyguanosine (OH 8 dG) in nuclear DNA, and superoxide dismutase (SOD) activity. OH 8 dG levels were significantly increased in HD caudate. Cytosolic SOD activity was slightly reduced in HD parietal cortex and cerebellum, whereas particulate SOD activity was unaltered in these regions. These results further support a role for metabolic dysfunction and oxidative damage in the pathogenesis of HD.

Integrity signals

Registry

Crossref · 10.1002/ana.410410514

Cites

40 of 40 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding
Bradford, M. M. (1976) · Analytical Biochemistry · doi:10.1016/0003-2697(76)90527-3 · Cited by 255,302
A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes
MACDONALD, M. (1993) · Cell · doi:10.1016/0092-8674(93)90585-e · Cited by 8,366
Neuropathological Classification of Huntingtonʼs Disease
VONSATTEL, J.-P., MYERS, R. H., STEVENS, T. J., FERRANTE, R. J., BIRD, E. D., & RICHARDSON, E. P. (1985) · Journal of Neuropathology and Experimental Neurology · doi:10.1097/00005072-198511000-00003 · Cited by 2,227
Self-citation
Does impairment of energy metabolism result in excitotoxic neuronal death in neurodegenerative illnesses?
Beal, M. F. (1992) · Annals of Neurology · doi:10.1002/ana.410310202 · Cited by 962
Self-citation
Glutamate becomes neurotoxic via the N-methyl-d-aspartate receptor when intracellular energy levels are reduced
Novelli, A., Reilly, J. A., Lysko, P. G., & Henneberry, R. C. (1988) · Brain Research · doi:10.1016/0006-8993(88)90765-2 · Cited by 961
Mitochondrial defect in Huntington's disease caudate nucleus
Gu, M., Gash, M. T., Mann, V. M., Javoy‐Agid, F., Cooper, J. M., & Schapira, A. H. V. (1996) · Annals of Neurology · doi:10.1002/ana.410390317 · Cited by 758
Oxidative damage to mitochondrial DNA shows marked age-dependent increases in human brain
Mecocci, P., MacGarvey, U., Kaufman, A. E., Koontz, D., Shoffner, J. M., Wallace, D. C., & Beal, M. F. (1993) · Annals of Neurology · doi:10.1002/ana.410340416 · Cited by 757
Self-citation
Huntingtin is a cytoplasmic protein associated with vesicles in human and rat brain neurons
DiFiglia, M., Sapp, E., Chase, K., Schwarz, C., Meloni, A., Young, C., Martin, E., Vonsattel, J.-P., Carraway, R., Reeves, S. A., et al. (1995) · Neuron · doi:10.1016/0896-6273(95)90346-1 · Cited by 749
Mutation of a nuclear succinate dehydrogenase gene results in mitochondrial respiratory chain deficiency
Bourgeron, T., Rustin, P., Chretien, D., Birch-Machin, M., Bourgeois, M., Viegas-Péquignot, E., Munnich, A., & Rötig, A. (1995) · Nature Genetics · doi:10.1038/ng1095-144 · Cited by 730
PURIFICATION OF AMINE OXIDASE FROM BEEF PLASMA
Tabor, C. W., Tabor, H., & Rosenthal, S. M. (1954) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)65591-7 · Cited by 725

Show all 41 references

Research works printed but not linked: 1

Tabor CW, 1954, Amine oxidases, J Biol Chem, 208, 645

Sorted by citations

Items 801–883 of 883

Envejecimiento: ADN mitocondrial y nuclear
Domínguez‐Garrido, E., & Pérez, M. J. L. (2012) · Monografías de la Real Academia Nacional de Farmacia
Zebrafish Models of Heme Synthesis and Iron Metabolism
Fraenkel, P. G. (2011) · Humana Press eBooks · doi:10.1007/978-1-60327-485-2_31
β-cell dysfunction in Huntington's disease
Bacos, K. (2009) · Lund University Publications (Lund University)
Strategies of neuroprotection in an in vivo model of retinal degeneration induced by mitochondrial dysfunction
Rojas-Martinez, J. C. (2009) · Texas ScholarWorks (Texas Digital Library)
Mitochondrial dysfunction in diabetes mellitus
Anderson, C. M. (1999) · Drug Development Research · doi:10.1002/(sici)1098-2299(199901)46:1 · Cited by 18
Inhibition of caspase-6: A potential therapy for Huntington’s disease
Quinn, M. (2008) · Dalhousie Medical Journal · doi:10.15273/dmj.vol35no1.3920
Studies of polyglutamine expanded Ataxin-7 toxicity
Yu, X. (2015) · KTH Publication Database DiVA (KTH Royal Institute of Technology)
A Genome-Wide RNAi Screen for Modifiers of Polyglutamine-Induced Neurotoxicity in Drosophila
Voßfeldt, H. (2013) · eDiss (Georg-August-Universität Göttingen) · doi:10.53846/goediss-3767
Bioenergetic Defects and Oxidative Damage in Transgenic Mouse Models of Neurodegenerative Disorders
Browne, S. E. (2003) · Defense Technical Information Center (DTIC) · doi:10.21236/ada419306
Self-citation
Kynurenines in neurological disorders
Mackay, G. (2007) · Enlighten: Theses (The University of Glasgow)
IN HEALTHY AND INJURED NEURONS
Chang, D. T. W. (2005)
UNIVERSIDADE FEDERAL DO RIO GRANDE DO SUL INSTITUTO DE CIÊNCIAS BÁSICAS DA SAÚDE PROGRAMA DE PÓS-GRADUAÇÃO EM CIÊNCIAS BIOLÓGICAS
Alegre, P. (2006)
Coenzyme Q10 and Behavior in Huntington’s Disease
Hickey, M. A. (2014) · Elsevier eBooks · doi:10.1016/b978-0-12-407824-6.00091-4
Mitochondrial DNA sequence variation in patients with sensorineural hearing impairment and in the Finnish population
Lehtonen, M. S. (2002)
Funktionelle Charakterisierung eines neuen Proteins mit einer Superoxiddismutase- Domäne
Hartung, H. (2013)
INFLUÊNCIA DO EXERCÍCIO FÍSICO SOBRE PARÂMETROS DE COMPORTAMENTO E ESTRESSE OXIDATIVO EM MODELO ANIMAL DE DISCINESIA TARDIA
Teixeira, A. M. (2008) · Americanae (AECID Library)
Modelling and treating Huntington’s disease: Generation of high-capacity adenovirus vectors to express normal and mutant huntingtin and to block huntingtin expression by short hairpin interference RNA
Huang, B. (2008) · OPen Access Repositorium der Universität Ulm (OPARU) (Ulm University) · doi:10.18725/oparu-1126
Tremor and Deep Brain Nuclei Hyperintensities in
Grunseich, C., Fishbein, T., Berkowitz, F. E., & Shamim, E. A. (2010)
Gene–Environment Interactions in Huntington’s Disease
Bichell, T. J., Uhouse, M. A., Bradley, E. M., & Bowman, A. B. (2015) · Elsevier eBooks · doi:10.1016/b978-0-12-800228-5.00017-0
Huntington's Disease: Unraveling the Pathophysiological Cascade Behind a Singular Gene Defect
Kosinski, C. M., Landwehrmeyer, G. B., & Ludolph, A. G. (2007) · Springer eBooks · doi:10.1007/978-0-387-30377-2_11
Role of Mitochondria in Parkinson’s Disease and Huntington’s Disease
Schapira, A. H. V. (2012) · Oxidative stress and disease · doi:10.1201/b12308-23
Protein Misfolding, Mitochondrial Disturbances, And Kynurenines In The Pathogenesis Of Neurodegenerative Disorders
Gárdián, G., Sas, K., Toldi, J., & Vécsei, L. (2009) · doi:10.1093/acprof:oso/9780195326697.003.0018
Oxidative Stress and Huntington’s Disease
Turner, C., & Schapira, A. H. V. (2003) · Oxidative stress and disease · doi:10.1201/9780203912874.ch20
Cyclosporin A Protects Striatal Neurons from Mitochondrial Dysfunction: Implications for Huntington's Disease
Leventhal, L., & Kordower, J. H. (2003) · Humana Press eBooks · doi:10.1385/1-59259-315-1:159
Reactive dopamine metabolites and neurotoxicity
Vanle, B., Doorn, J. A., Duffel, M. W., Quinn, D. M., Roman, D. L., & Kerns, R. J. (2016) · doi:10.17077/etd.28c5nhya
"Analysis of peripheral tissues and cell lines from patients with Huntington's disease for searching biomarkers" "Studio dei meccanismi patogenetici attraverso l'analisi di tessuti periferici e linee cellulari nella malattia di Huntington per la ricerca di nuovi biomarkers"
Ricerca, D. I. D., & Orobello, S. (2010)
A REVIEW ON- ANTIOXIDANTS
Tejasri, M., Kumar, D., Ramya, M., Revathi, K., Avinash, G., & Reddy, K. H. (2012)
Neuropathological characterization of FL-PGC-1α-deficient mice – implications for mitochondrial encephalopathy
Szalárdy, L. (2016) · SZTE Repository of Dissertations (University of Szeged) · doi:10.14232/phd.3120 · Cited by 1
The effect of mitochondrial toxins on cytochrome c oxidase subunit IV isoforms and its consequences on mitochondrial function and neural cell survival
Misiak, M., & Arnold, S. (2010) · RWTH Publications (RWTH Aachen)
The Effects of Exogenous Ubiquinone on Mitochondrial Function, Oxidative Damage, and Lifespan in Caenorhabditis elegans
Yang, Y. (2010) · OhioLink ETD Center (Ohio Library and Information Network)
Defective Dynamics Of Mitochondria In Amyotrophic Lateral Sclerosis And Huntington's Disease
Song, W. (2012) · Journal of International Crisis and Risk Communication Research
Identification and Biophysical Characterization of Small Molecules Modulating Protein Disulfide Isomerase in Neurodegenerative Diseases
Kaplan, A. R. (2015) · doi:10.7916/d8sx6c9b
Cytochrome c oxidase mediates the regulation of mitochondrial function in an in vitro model of Huntington's disease
Singh, S., & Wagner, H. N. (2009) · RWTH Publications (RWTH Aachen)
Human wild-type superoxide dismutase 1 gene delivery to rat bone marrow stromal cells: its importance and potential future trends.
Abedi, M., Mesbah‐Namin, S. A., Noori-Zadeh, A., Tiraihi, T., & Taheri, T. (2018) · Europe PMC (PubMed Central) · doi:10.22038/ijbms.2018.27721.6879
A Proteomic Analysis of Mitochondrial Complex III Inhibition in SH-SY5Y Human Neuroblastoma Cell Line
Acıoğlu, Ç., Tüzüner, M. B., Serhatlı, M., Açılan, C., Şahin, B., Akgün, E., Adıgüzel, Z., Gürel, B., & Baykal, A. T. (2018) · Current Proteomics · doi:10.2174/1570164615666180713110139
Inherited Neurodegenerative Disorders
Sumathipala, D., & Dissanayake, V. H. W. (2018) · Springer eBooks · doi:10.1007/978-981-13-0944-1_7
Striatal Neurodegeneration that Mimics Huntington’s Disease Modifies GABA-induced Currents
Flores‐Hernández, J., Garzón-Vázquez, J. A., Carballo, L. G. H., Nieto-Mendoza, E., Ruíz-Luna, E. A., & Hernández, E. (2018) · Brain Sciences · doi:10.3390/brainsci8120217
Cyclosporin A Protects Striatal Neurons from Mitochondrial Dysfunction
Leventhal, L., & Kordower, J. H. (2003) · Humana Press eBooks · doi:10.1007/978-1-59259-315-6_8
Molecular Mechanisms Underlying the Role of Mitophagy in Neurodegeneration
Ahlawat, A., Kaira, M., Walia, V., & Garg, M. (2020) · Advances in medical diagnosis, treatment, and care (AMDTC) book series · doi:10.4018/978-1-7998-1317-0.ch003
Huntington's Disease
Browne, S. E., & Beal, M. F. (2001) · Elsevier eBooks · doi:10.1016/b978-012351830-9/50051-2
Self-citation
Gene-environment interactions between mutant huntingtin and manganese exposure alter striatal neurochemistry and medium spiny neuron morphology.
Madison, J. L. (2011)
Huntingtin Maintains Mitochondrial Genome Integrity and FunctionPreprint
Pradhan, S., Gao, R., Bush, K. M., Zhang, N., Smith-Geater, C., Chakraborty, A., Morozko, E. L., Dickey, A. S., Yuan, S., Snowden, J., et al. (2021) · SSRN Electronic Journal · doi:10.2139/ssrn.3869898
Structure/Function Analysis of the Huntingtin N-terminus Encoded by Htt Exon 1 Using Knock-In Mouse Models
André, E. A. (2017) · doi:10.18130/v3865r
Polyglutamine Diseases
Friedman, M. J., Li, S.-H., & Li, X. (2007) · Springer eBooks · doi:10.1007/3-540-33336-3_9
The paradigm of Huntington’s disease: Therapeutic opportunities in neurodegeneration
Leegwater‐Kim, J., & Cha, J.-H. J. (2004) · Neurotherapeutics · doi:10.1007/bf03206573
Faculty Opinions recommendation of Inhibition of mitochondrial protein import by mutant huntingtin.
Donato, S. D. (2014) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.718391846.793501957
Oxidative stress modulation in neurodegenerative diseases
Carlesi, C., Ienco, E. C., Piazza, S., Gerfo, A. L., Alessi, R., Pasquali, L., & Siciliano, G. (2011) · Mediterranean Journal of Nutrition and Metabolism · doi:10.1007/s12349-011-0055-x
An investigation into the mechanism of proteasome dysfunction in neurodegenerative disease and the biological impact of proteasome hyperactivation in C. elegans
Anderson, R. T. (2022) · The Research Repository @ WVU (West Virginia University) · doi:10.33915/etd.11619
Buccal Respiratory Chain Complexes I and IV Quantities in Huntington’s Disease Patients
Dušek, P., Rodinová, M., Lišková, I., Klempíř, J., Zeman, J., Roth, J., & Hansíková, H. (2018) · Folia Biologica · doi:10.14712/fb2018064010031
A Journey through Huntington's Disease: Exploring Genetics, Neurobiology, and Therapeutic Advances
-, S. D., -, S. K., -, S. S., & -, J. M. (2024) · International Journal For Multidisciplinary Research · doi:10.36948/ijfmr.2024.v06i03.19194
Güncel Biyokimya Çalışmaları VII
Atıcı, Y., Ökten, Z., Kasebi, S., Arıkan, B. S., Erdem, M., Kıran, T. R., Yağız, A. K., Aktolun, B., Demirağcı, Y. G., Kara, H., et al. (2024) · Akademisyen Kitabevi eBooks · doi:10.37609/akya.3109
THE RELATIONSHIP BETWEEN OXIDATIVE STRESS AND NEUROLOGICAL DISORDERS: MINI REVIEW
Kulbayeva, Z., Klyuyev, D. A., Sh, S. K. (., & Muratbek, A. A. (2024) · Farmaciâ Kazahstana · doi:10.53511/pharmkaz.2024.36.46.010
Differential regulation of G protein‐coupled receptor‐associated proteins in the caudate and the putamen of cynomolgus macaques following chronic ethanol drinking
Neel, A. I., Wang, Y., Sun, H., Liontis, K. E., McCormack, M. C., Mayer, J. C., Cervera‐Juanes, R. P., Davenport, A. T., Grant, K. A., Daunais, J. B., et al. (2024) · Journal of Neurochemistry · doi:10.1111/jnc.16134
Dopamine-Dependent Long-Term Potentiation Induced by 3-Nitropropionic Acid in Striatal Medium Spiny Neurons
Pisani, A., Bonsi, P., Gubellini, P., Centonze, D., Tolu, M., Bernardi, G., & Calabresi, P. (2002) · Advances in behavioral biology · doi:10.1007/978-1-4757-3538-3_43
The clinical utility of multidisciplinary rehabilitation in individuals with Huntington’s Disease
Cruickshank, T. M. (2015) · Australasian Journal of Paramedicine
Étude de l'implication potentielle des marqueurs du striatum dans la maladie de Huntington
Galvan, L. (2011) · theses.fr (ABES) · doi:10.70675/ebf9c275z3ce2z474dz8d5az68c2c35df509
Etude fonctionnelle de deux marqueurs régionaux du cerveau chez la souris
Caudy, N. (2011) · doi:10.70675/dd14da53za75fz485dz971fz99a3a9244ab4
Trafficking Regulation and Energetics
Rivas, M. V. H. (2014) · theses.fr (ABES) · doi:10.70675/5ffde918zb7aaz4749z8ad1ze7a28ef65de9
Importance du contrôle qualité des mitochondries dans les maladies neurodégénératives : analyse cellulaire et génétique dans des modèles drosophile de la maladie de Huntington et de la sclérose latérale amyotrophique
Khalil, B. (2016) · theses.fr (ABES) · doi:10.70675/4446111fz4182z4737zae76z7f117887a893
Amélioration d'un composé actif contre la maladie de Huntington
Marelli, C. (2015) · doi:10.70675/d7ca753fz9194z4e5cz8822z06d59c72779b
A Study of Striatal Markers as Disease Modifiers in Huntington's Disease
Francelle, L. (2014) · theses.fr (ABES) · doi:10.70675/ac372f63z7712z4632z8782z6b71a643add2
Développement de l’imagerie métabolique par IRM-CEST : application à la maladie de Huntington
Pépin, J. (2018) · theses.fr (ABES) · doi:10.70675/36f26e42z6133z47dbz84a3z07fae7850aa0
Reconstitution du réseau corticostriatal et cible thérapeutique dans la maladie de Huntington
Virlogeux, A. (2018) · theses.fr (ABES) · doi:10.70675/92b9e042zfafcz42e8z890bz6c7ca43e2613
Role of the cholesterol hydroxylase enzyme CYP46A1 in cholesterol metabolism and neuroprotection in Huntington's disease
Kacher, R. (2019) · theses.fr (ABES) · doi:10.70675/2e6ac10bz0700z4936z81f8z18565a62aaf5
Rôle des altérations transcriptionnelles et épigénétiques dans les déficits comportementaux de la maladie de Huntington
Lotz, C. (2019) · theses.fr (ABES) · doi:10.70675/35213e27zda27z484az886azd1ed4013e75a
Rôle de la dérégulation neuronale de la protéine kinase activée par l’AMP (AMPK) dans la pathologie tau, l’intégrité des synapses et le métabolisme énergétique : relevance pour la maladie d’Alzheimer
Domise, M. (2018) · theses.fr (ABES) · doi:10.70675/43c1f12fze623z41e8z970fz64a5de94a299
The role of the serum response factor in the pathogenesis of Huntington's disease
Awada, A. (2021) · theses.fr (ABES) · doi:10.70675/fabef4b5z9d78z440bz99f2z9be7d0814a03
Investigating the molecular signature of reactive astrocytes mediated by the JAK2- STAT3 pathway using different omics : transcriptomics and proteomics insights
Riquelme‐Perez, M. (2023) · theses.fr (ABES) · doi:10.70675/72aad0d8z36a8z4a7azb1eaze65fa79463da
Déficits développementaux du circuit striatal chez des modèles murins de la maladie de Huntington
Lebouc, M. (2023) · theses.fr (ABES) · doi:10.70675/f136158dz8184z4417z99f6z6f1479f2dcbe
Maladie de Huntington : huntingtine, connectivité neuronale et métabolisme oxydatif
Capellano, L. (2025) · theses.fr (ABES) · doi:10.70675/dd0b8f65z490fz446fz8d1azd0dd5619a044
Sensitive determination of 8-OHdG in artificial saliva using DPAdSV at an unmodified edge-plane pyrolytic graphite electrode
Gunduz, C., Orhan, D. E., & Dogan‐Topal, B. (2026) · Microchemical Journal · doi:10.1016/j.microc.2026.118056
Experimental Models of Polyglutamine Disorders
Satheesh, P., & Tuma, J. (2026) · Contemporary clinical neuroscience · doi:10.1007/978-3-032-18296-8_17
The CYP27A1–VDR Feedback Rheostat Controls Mitochondrial Protein Homeostasis and Preserves Hippocampal-Striatal Network Integrity to rescue Cognitive impairment in HD conditionPreprint
Kumar, V., Kodam, P., Kunja, C., Brahmandam, G., Balasubramanyam, S. N., Patel, S., Skv, M., Chakravarty, S., Sanyal, A., Komal, P., et al. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.06.11.731670
Targeting mtDNA to Modulate Mitochondrial Dysfunction in Neurodegenerative Diseases
Pramanik, S., Debnath, B., Chakraborty, A. J., Islam, A., Mullick, S., Chaudhary, P., Nath, R., Chellappan, D. K., Mondal, M., & Ashique, S. (2026) · Molecular Neurobiology · doi:10.1007/s12035-026-06008-2
Redox Dysregulation in Neurodegeneration: Molecular Mechanisms and Therapeutic Perspectives
Ramirez-Celis, C., Navarro‐Mabarak, C., Morán, J., & Martínez-Torres, V. S.-M. A. A. M. (2026) · IntechOpen eBooks · doi:10.5772/intechopen.1016301
Mitochondrial dynamics in Huntington's disease
Paiva, B., & Rego, A. C. (2026) · Journal of Huntington s Disease · doi:10.1177/18796397261478163
Early Administration of Methylene Blue Attenuates Mitochondrial Dysfunction and Cognitive Deficits in a Model of Huntington’s Disease
Huerta‐Cervantes, M., Peña‐Montes, D. J., López‐Vázquez, M. A., Saavedra‐Molina, A., Pérez-Vega, M. I., & Olvera‐Cortés, M. E. (2026) · Biology · doi:10.3390/biology15201801
Magnetic resonance imaging in Huntington’s disease
Orth, M. (2026) · Advances in magnetic resonance technology and applications · doi:10.1016/b978-0-443-21425-7.00009-9
Efeito da administração intraestriatal aguda de ácido quinolínico sobre metabolismo energético em ratos jovens
Ribeiro, C. A. J. (2006) · Americanae (AECID Library)
Huntingtin Nuclear Localization: Current Insights into Mechanism and Regulation
Desmond, C. R. (2012) · MacSphere (McMaster University) · doi:10.71548/9066
Therapeutic Silencing of Mutant Huntingtin by Targeting Single Nucleotide Polymorphisms: A Dissertation
Pfister, E. L. (2012) · The Journal of the American Medical Association (JAMA) Network (American Medical Association) · doi:10.13028/a5gf-1e13
CHARACTERIZING THE FUNCTION OF HUNTINGTIN IN THE CELL STRESS RESPONSE AS A TARGET FOR DRUG DISCOVERY IN HUNTINGTON’S DISEASE
Munsie, L. N. (2012) · MacSphere (McMaster University) · doi:10.71548/10111
GENE AND CELLULAR TRANSPLANTATION THERAPIES FOR HUNTINGTON'S DISEASE
Ramaswamy, S., & Kordower, J. H. (2008) · Elsevier eBooks · doi:10.1016/b978-012373994-0.50013-0

Authors: Browne, S. E., Bowling, A. C., Macgarvey, U., Baik, M. J., Berger, S. C., Muquit, M. M. K., Bird, E. D., & Beal, M. F.
Affiliations: Harvard University (US)
McLean Hospital (US)
Corresponding author: Beal, M. Flint
ORCID: Browne, Susan E.
Beal, M. Flint
Venue: Annals of Neurology
Publisher: Wiley
Published: 1997-05
Volume: 41
Issue: 5
Pages: 646-653
ISSN: 0364-5134 (ISSN-L)
1531-8249
DOI: 10.1002/ana.410410514
OpenAlex: W2102430316
Cited by: 885
References: 41
Citations by year: 2026: 14 · 2025: 12 · 2024: 18 · 2023: 17 · 2022: 25 · 2021: 33 · 2020: 22 · 2019: 18 · 2018: 31 · 2017: 13 · 2016: 47 · 2015: 31 · 2014: 41 · 2013: 37 · 2012: 46
FWCI: 10.37
Type: journal article
Language: en
Open access: closed
Licence: onlinelibrary.wiley.com/termsAndConditions#vor (vor, 2717 d)
Locations: Annals of Neurology (publishedVersion)
PubMed (publishedVersion)
Topics: Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Genetic Neurodegenerative Diseases
Life Sciences › Biochemistry, Genetics and Molecular Biology › Clinical Biochemistry › Metabolism and Genetic Disorders
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Mitochondrial Function and Pathology
Keywords: Huntington's disease, oxidative damage, metabolic dysfunction, basal ganglia, selective neuronal vulnerability, oxidative phosphorylation, complex IV activity, complex I, glyceraldehyde-3-phosphate dehydrogenase, huntingtin, 8-hydroxy-2'-deoxyguanosine, superoxide dismutase, caudate nucleus, putamen, postmortem brain
MeSH terms: Basal Ganglia, Cerebellum, Cerebral Cortex, DNA, Glyceraldehyde-3-Phosphate Dehydrogenases, Humans, Huntington Disease, Mitochondria, Oxidation-Reduction, Reference Values, Spectrophotometry, Stress, Physiological, Superoxide Dismutase, NAD(P)H Dehydrogenase (Quinone), In Vitro Techniques

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Oxidative damage and metabolic dysfunction in Huntington's disease: Selective vulnerability of the basal ganglia

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks